Background: Previous work has shown that all-trans-retinoic acid reverses elastase induced emphysema in rats. Since there is currently no effective treatment for pulmonary emphysema, the effect of retinoic acid should be further investigated in other adult species. A study was undertaken using two murine models of emphysema to evaluate the effect of retinoic acid. Methods: The models used were an elastase induced emphysema model for acute alveolar destruction and a tumour necrosis factor (TNF)-a transgenic mouse which exhibits chronic air space enlargement, loss of elastic recoil, increased lung volume, and pulmonary hypertension comparable to human pulmonary emphysema. All-trans-retinoic acid (2 mg/kg) was injected for 12 successive days after the establishment of emphysema. The effects of treatment were evaluated using physiological and morphometric analyses. Results: In contrast to the rat, administration of all-trans-retinoic acid in these murine models did not improve the emphysema. Moreover, worsening of emphysema was observed in TNF-a transgenic mice treated with all-trans-retinoic acid. The level of keratinocyte chemoattractant (KC), a CXC chemokine, in bronchoalveolar lavage fluid was increased in TNF-a transgenic mice following retinoic acid treatment. These data raise the possibility that retinoic acid causes deterioration of emphysema by promoting inflammation in this model. Conclusions: In these models, retinoic acid did not show positive effects on emphysema. The effect of retinoic acid in the treatment of pulmonary emphysema remains controversial, and further studies are required to determine its physiological effects under a variety of experimental conditions.
P ulmonary emphysema is a serious disease characterised by reduced maximal expiratory flow, increased lung volume, and alveolar wall destruction. 1 There is a strong relationship with tobacco smoking, and as many as 2 million people in the United States suffer from pulmonary emphysema. Furthermore, the prevalence seems to be increasing. Although there has been extensive research into the molecular mechanisms underlying the development of emphysema, the clinical management of patients with pulmonary emphysema remains mostly supportive. There is no proven clinically effective treatment to promote recovery from established emphysema. 2 3 Recently, all-trans-retinoic acid has been reported to reverse elastase induced emphysema in rats. 4 Administration of all-trans-retinoic acid, a metabolite of retinol (vitamin A), to rats with elastase induced emphysema attenuated alveolar destruction and increased the alveolar number, resulting in normal alveolar morphometry. Although retinoic acid had a positive effect when given to mice aged less than 2 months, 5 it has not been found to have a beneficial effect on the recovery from emphysema in any adult animal model other than the rat. In addition, a recent clinical trial of all-trans-retinoic acid in the treatment of chronic obstructive pulmonary disease (COPD) did not result in any improvement. 6 The aim of this study was to determine the effect of retinoic acid on pulmonary emphysema in mice using two murine models of air space enlargement-namely, treatment with elastase 4 and surfactant protein (SP)-C/tumour necrosis factor (TNF)-a transgenic mice. The transgenic mouse constitutionally overexpresses TNF-a under the SP-C promoter and develops air space enlargement, loss of elastic recoil, increased lung volumes, and ultimately pulmonary hypertension. 7 8 This model is particularly appropriate since TNF-a is considered to be an important factor in the development of pulmonary emphysema. 9 
METHODS

Animals
Eight week old C57BL/6 female mice were used in the study. Porcine pancreatic elastase was purchased from Elastin Product Co (Owensville, MI, USA). After anaesthesia with bromoethanol, a 22 gauge feeding tube with a tip bent to 45 degrees was inserted into the trachea and advanced into the left bronchus. Three units of elastase in 50 ml saline were injected into the left lung. SP-C/TNF-a transgenic mice bred into the C57BL/6 background were also used. Transgenic male mice were crossed with normal C57BL/6 female mice and bred in an animal facility documented to be free of murine specific pathogens. Mice were genotyped and transgenic negative littermates were used as controls. Female mice aged 24-28 weeks were studied because emphysematous change is complete at this age. Pulmonary physiology, histology, and morphometry After 12 days of treatment with retinoic acid or cottonseed oil, a number of pulmonary physiological parameters were examined using previously described methods. 7 The mice were then killed by intraperitoneal injection of sodium pentobarbital. Lungs were inflated at 25 cm H 2 O static pressure by intratracheal instillation of 4% paraformaldehyde in phosphate buffered saline (PBS). Tissue sections were stained with haematoxylin and eosin and morphometric studies were performed as described previously. 7 10 The mean linear intercept (Lm), an indicator of air space size, was calculated for each mouse from 10 randomly selected fields at a magnification of 6200 using a 21 line counting grid.
Bronchalveolar lavage (BAL) studies
After insertion of a tracheal tube, the trachea was lavaged five times with 1 ml aliquots of PBS. Cells in the lavage fluid were counted with a haemocytometer. Differential cell counts of BAL fluid were performed on 200 cells from a smear stained with a modified Wright's stain (DiffQuik; American Scientific Products, McGas Park, IL, USA). For gelatin zymography, 40 ml of BAL fluid was electrophoresed in a sodium dodecyl sulfate-polyacrylamide (SDS) gel containing 1% gelatin under non-reducing conditions as described previously. 7 The level of keratinocyte chemoattractant (KC) in the BAL fluid was measured by enzyme linked immunosorbent assay (ELISA) according to the manufacturer's instructions (Genzyme Techne, Minneapolis, MN, USA).
Statistical analysis
Data are expressed as mean (SE) values. The statistical analyses were performed using SAS software, Version 6. Analysis of variance (ANOVA) was performed, using the Tukey-Kramer test to adjust for multiple comparisons. A p value of ,0.05 was considered to indicate a significant difference.
RESULTS
Retinoic acid toxicity
In a preliminary experiment the same dose of retinoic acid (500 mg/kg) as was used to treat elastase induced emphysema in rats 4 was given to four TNF-a transgenic mice and their littermates. No significant histological or physiological differences were found between the retinoic acid and cottonseed oil groups. Moreover, retinoic acid given in a dose of 100 mg/kg also resulted in no significant differences in the pathophysiology in TNF-a transgenic mice and their littermates (n = 3 each). As a result, the dose of retinoic acid was increased to 2 mg/kg. Retinoic acid administration did not produce noticeable morbidity and mortality. Although Meshi et al 11 reported excess deaths in guinea pigs treated with retinoic acid, no mice died in this experiment. Body weights were measured during the administration of cottonseed oil and retinoic acid and there was no difference between the control and experimental groups. The number of mice, body weight, and lung volumes are summarised in table 1.
Effect of retinoic acid on elastase induced emphysema
Elastase administration into the left lung induced severe haemorrhagic pneumonia on day 1. There was progressive alveolar destruction which resulted in emphysema and air space enlargement 28 days later. Intraperitoneal administration of retinoic acid was started 28 days after elastase administration and continued for 12 successive days. Histopathological examination indicated no obvious difference between retinoic acid treated mice and controls ( fig 1A) , and this was confirmed by morphometric analysis ( fig 1B) . Elastase treatment produced a marked increase in Lm which was not reduced by retinoic acid. Administration of cottonseed oil did not induce any structural pulmonary changes compared with administration of saline ( fig 1A) .
Effect of retinoic acid in TNF-a transgenic mice SP-C/TNF-a transgenic mice developed alveolar enlargement, increased lung volumes, and chronic inflammation at 6 months of age, as previously reported. 7 Retinoic acid did not affect the gross histology of the lungs of TNF-a transgenic mice (fig 2A) . The presence of small alveoli, previously reported in elastase induced emphysema in rats following retinoic acid treatment, were not observed in TNF-a transgenic mice treated with retinoic acid. Morphometric analysis indicated a tendency for retinoic acid to induce alveolar enlargement in TNF-a transgenic mice although this was not statistically significant ( fig 2B) . Six transgenic mice and six littermates were each treated with either cottonseed oil or retinoic acid.
Pulmonary physiology
The pressure-volume (PV) relationships in the various experimental groups are shown in fig 3. Administration of retinoic acid resulted in a left shift of the PV curve in TNF-a transgenic mice, indicating the development of more severe and progressive emphysematous changes, but there was no change in the PV relationship in the littermates. Total lung capacity (TLC) and static expiratory compliance (Cstat) were increased in TNF-a transgenic mice following retinoic acid administration, but functional residual capacity (FRC) was unchanged (fig 4) . These data indicate that retinoic acid administration induced a deterioration in emphysema-like changes in TNF-a transgenic mice. In the murine elastase induced emphysema model the effect of treatment was evaluated by morphometry since the disease is localised to the left lung in this model.
Analyses of cells counts, metalloproteinases and chemokine levels in BAL fluid BAL fluid was collected from both retinoic acid and cottonseed oil treated mice in both models and cell counts performed. Four mice in each group were used for this experiment. Treatment of mice with elastase induced emphysema with retinoic acid did not result in any significant change in the differential cell count of BAL fluid (data not shown). Neutrophils were increased in BAL fluid from TNF-a transgenic mice before retinoic acid treatment as previously described. 7 However, no difference was apparent between transgenic mice treated with retinoic acid or cottonseed oil (fig 5) .
Matrix metalloproteinases (MMPs) have been reported to account for the development of COPD. 12 Indeed, BAL fluid from TNF-a transgenic mice exhibited MMP activity, mainly gelatinase. 7 BAL fluid from mice treated with retinoic acid or cottonseed oil was examined by gelatin zymography but no difference in gelatinase activity was observed between the two groups in either the elastase induced emphysema model or in TNF-a transgenic mice (data not shown).
KC is a CXC chemokine which plays an important role in neutrophil accumulation while interleukin 8 (IL-8), a human CXC chemokine, has been reported to contribute to the development of pulmonary emphysema. 13 Since retinoic acid has been reported to induce IL-8, the concentration of KC in BAL fluid from retinoic acid treated mice was measured by ELISA. The BAL fluid concentration of KC was significantly increased until 1 day after the administration of elastase and was undetectable at 28 days ( fig 6A) . In wild type mice no significant difference was observed in the BAL fluid concentration of KC between groups treated with retinoic acid or cottonseed oil. In fact the BAL fluid concentration of KC level was significantly higher in retinoic acid treated TNF-a transgenic mice than in TNF-a transgenic mice treated with cottonseed oil (fig 6B) . In addition, TNF-a transgenic mice treated with cottonseed oil had higher levels of KC than transgene negative littermates.
DISCUSSION
Emphysema is regarded as a progressive disease related to cigarette smoking, with no effective treatment after emphysematous changes have been established. A report that retinoic acid can restore the normal lung structure in rats with established elastase induced emphysema 4 was therefore of considerable interest. In addition, a small study reported a reduced concentration of vitamin A in patients with moderate to severe COPD with an improvement in pulmonary function testing being achieved after vitamin A supplementation. 14 These data suggested that retinoic acid administration may represent a new treatment for human emphysema. However, in a recent clinical trial of the effect of all-trans-retinoic acid in patients with COPD, no significant improvement was achieved. 6 In addition, retinoic acid did not promote recovery from smoking induced emphysema in the guinea pig. 11 These studies suggest that the beneficial effect of retinoic acid treatment may be species specific. We therefore examined the effect of retinoic acid in murine models of emphysema.
In the murine elastase induced emphysema model we evaluated the effect of treatment by morphometry alone since disease is localised to the left lung in this model. No significant histological changes were seen following retinoic acid treatment, and we therefore conclude that it is ineffective in promoting recovery in the elastase model of emphysema in mice. This finding is consistent with the study recently reported by Lucey et al 15 in which retinoic acid was started at day 22 after elastase administration. We speculate that retinoic acid does not affect alveolar septation in the murine model. TNF-a transgenic mice have increased lung volumes, loss of elastic recoil, destruction of alveolar walls, and pulmonary hypertension. 7 8 Since these changes progress with age, chronic inflammation induced by TNF-a plays an important role in developing emphysema. These mice appeared to show emphysematous changes rather than pulmonary fibrosis as originally reported. 16 In these mice retinoic acid also failed to reverse the emphysema as defined by both morphometric and physiological parameters. It had no effect on the morphometric measurement of alveolar size but appeared to have a tendency to cause deterioration of emphysematous changes, although the difference was not statistically significant. Physiological assessment showed an increase in TLC, static compliance, and a left shift in the PV curve. These physiological data indicate a deterioration in pulmonary emphysema in TNF-a transgenic mice after retinoic acid (2)) treated with retinoic acid (RA) or cottonseed oil (OIL). Each group consisted of four mice. There was no significant difference between RA and OIL treatments. treatment. Since the finding of increased lung volume and decreased elastic recoil following treatment with retinoic acid in TNF-a transgenic mice was unexpected, the mechanism underlying the deterioration in lung function induced by retinoic acid was investigated further.
Vitamin A is known to have a critical role in the differentiation, growth, and health of lung epithelial cells. Vitamin A deficiency results in a loss of mucus secreting epithelium because cells are unable to differentiate normally and develop as layers of keratinising squamous epithelium. 17 This finding led to a clinical trial to establish if vitamin A supplementation might prevent lung cancer, but vitamin A and b carotene both caused an increase in the incidence of lung cancer compared with a control group. 18 The reason for this adverse result remains unclear, although some researchers have reported that vitamin A might induce inflammation which may outweigh its beneficial antioxidant effects. [19] [20] [21] Retinoic acid may induce DNA damage. 20 Moreover, Harant et al reported that simultaneous treatment with retinoic acid and TNF-a resulted in an increase in the IL-8 mRNA level in vitro. 19 This induction is likely to result from the interaction of retinoic acid with the NF-kB site and IL-8 promoter. 21 In addition, retinoic acid upregulateed TNF receptors and potentiated TNF induced activation of NF-kB, activated protein 1, and apoptosis. 22 This is of interest since the human CXC chemokine IL-8 is associated with the development of pulmonary emphysema. Neutrophil infiltration induced by IL-8 causes alveolar destruction through neutrophil elastase and MMP activation. 13 In the present study we found that the concentration of the CXC chemokine KC was increased early in the course of elastase induced emphysema in mice. In addition, a higher level of KC was found in the BAL fluid of TNF-a transgenic mice with emphysema than in control littermates. We therefore consider that KC actively contributes, at least in part, to the development of emphysema in mice. TNF-a transgenic mice treated with retinoic acid had a higher KC level than controls. The increase in KC after retinoic acid was only seen in the TNF-a transgenic mice. Although there was a tendency to increased neutrophil accumulation in TNF-a transgenic mice treated with retinoic acid, it was not statistically significant. A similar finding has been observed in humans. The level of IL-8 in BAL fluid was correlated with neutrophil elastase/a 1 -protease complex inhibitor but not with neutrophil numbers. 13 It is probably difficult to show a significant increase in neutrophil accumulation by KC in TNF-a transgenic mice since these mice already have high levels of neutrophils in their BAL fluid. An alternative explanation might be the increase in KC stimulated neutrophil function in TNF-a transgenic model treated with retinoic acid.
On the other hand, retinoic acid has been reported to reduce intrapulmonary inflammation, 23 24 but we do not know the precise reason for the difference. Further studies are needed to clarify this controversy.
These data indicate that retinoic acid does not induce regeneration of alveoli in mice with established emphysema. In contrast to the elastase induced model of pulmonary emphysema, TNF-a transgenic mice exhibit persistent inflammation during the period of retinoic acid administration. Pulmonary emphysema was therefore exacerbated by retinoic acid. This suggests that the presence of severe inflammation might be a risk factor for worsening of alveolar injury following retinoic acid treatment. Moreover, treatment with retinoic acid in a guinea pig model of smoking induced emphysema resulted in increased deaths. 11 In view of the fact that current thinking suggests an important central role for inflammation in the pathogenesis of COPD, care should be taken when considering the use of all-trans-retinoic acid as a potential therapeutic agent in patients with COPD, especially during the early phase of the disease.
It is difficult to know why retinoic acid has different effects in rats and mice since lung retinoid signalling is highly conserved. [25] [26] [27] [28] [29] It is also difficult to interpret the different effects of retinoic acid in different models of emphysema such as elastase or overexpression of TNF-a. It is possible that the effect of retinoic acid is specific to the model, especially inflammation. TNF-a transgenic mice still had inflammation when retinoic acid was administered, as shown by BAL fluid analysis. Another possible explanation is the age of the animals. In this study we used 8 week old mice for the elastase model and 24-28 week old transgenic mice. Even in the same background (C57Bl/6), the effect of retinoic acid on emphysema was different. Previous studies have used 4 month old rats in the elastase induced emphysema model and reported recovery from emphysema. 4 15 It has previously been shown that retinoic acid affected the emphysema model when administered to mice less than 2 months of age. 5 In older mice the ability to generate alveoli may be lost and administration of retinoic acid may also result in inflammation. Another possibility is the dose of retinoic acid used. We used a dose of retinoic acid that was four times larger than the dose used in rats. 4 Other unknown mechanisms for controlling alveoli generation may exist and should be investigated in further studies.
In summary, retinoic acid may exert disparate effects in emphysema with either resolution or exacerbation depending on the dose used, the age and species of animal, and the degree of underlying inflammation. The dose and duration of administration of retinoic acid should therefore be considered carefully in clinical trials. Further study is required to determine the effect of retinoic acid on emphysema.
